For research use only. Not for therapeutic Use.
Cenobamate (CAS 913088-80-9) is a medication approved for the treatment of focal-onset seizures in adults. As an antiepileptic drug, Cenobamate acts by modulating sodium currents in the brain, which helps prevent abnormal electrical activity associated with seizures. Its unique mechanism of action sets it apart as a treatment option for individuals with epilepsy who may not respond adequately to other available medications.
| Catalog Number | I048017 |
| CAS Number | 913088-80-9 |
| Synonyms | Xcopri; YKP3089 |
| Molecular Formula | C10H10ClN5O2 |
| Purity | 98% |
| Target Protein | GFHAXPJGXSQLPT-VIFPVBQESA-N |
| Appearance | Solid |
| IUPAC Name | [(1R)-1-(2-chlorophenyl)-2-(tetrazol-2-yl)ethyl] carbamate |
| InChI | InChI=1S/C10H10ClN5O2/c11-8-4-2-1-3-7(8)9(18-10(12)17)5-16-14-6-13-15-16/h1-4,6,9H,5H2,(H2,12,17)/t9-/m0/s1 |
| InChIKey | GFHAXPJGXSQLPT-VIFPVBQESA-N |
| SMILES | C1=CC=C(C(=C1)C(CN2N=CN=N2)OC(=O)N)Cl |
